Jcr Pharmaceuticals Regains Full Commercialization Rights To Jr-141
JCR Pharmaceuticals Co Ltd 4552.T :
* JCR PHARMACEUTICALS CO LTD- JCR PHARMACEUTICALS REGAINS
FULL
COMMERCIALIZATION RIGHTS TO JR-141
* JCR PHARMACEUTICALS CO LTD: JCR PHARMACEUTICALS REGAINS
FULL
COMMERCIALIZATION RIGHTS TO JR-141
Source text for Eikon: ID:nTSry831c4
Further company coverage: 4552.T
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results